Tejas Savant Analyst PerformanceExecutive Director / Senior Healthcare Equity Analyst at Morgan StanleyTejas Savant is a stock analyst at Morgan Stanley focused in the medical sector, covering 18 publicly traded companies. Over the past year, Tejas Savant has issued 34 stock ratings, including buy, hold, and sell recommendations. While full access to Tejas Savant's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tejas Savant's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings57 Last 4 YearsBuy Recommendations39.29% 22 Buy RatingsCompanies Covered18 Unique Companies Ratings Distribution56RatingsDistribution of strong buy, buy, hold, and sell ratings by Tejas Savant.RatingPercentageCount Strong Buy0.0%0 ratings Buy39.3%22 ratings Hold53.6%30 ratings Sell7.1%4 ratingsOut of 56 total stock ratings issued by Tejas Savant at Morgan Stanley, the majority (53.6%) have been Hold recommendations, followed by 39.3% Buy and 7.1% Sell.Best & Worst CallsBest Call0000.0%TXGMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AVTRFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ77.8% of companies on NASDAQ14 companiesNYSE22.2% of companies on NYSE4 companiesTejas Savant, an analyst at Morgan Stanley, currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies94.4%Transportation1 company5.6%Tejas Savant of Morgan Stanley specializes in stock coverage within the Medical sector, with additional focus on Transportation companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE6 companies33.3%MED INSTRUMENTS4 companies22.2%MEDICAL INFO SYS2 companies11.1%MEDICAL SERVICES2 companies11.1%MED - GENERIC DRG1 company5.6%MED - DRUGS1 company5.6%TRANS - SERVICES1 company5.6%MED PRODUCTS1 company5.6% Tejas Savant's Ratings History at Morgan Stanley Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPSNLPersonalis5/12/2026Lower Price Target$5.86$9.00Equal Weight$0.0000.00% ROICTKBCytek Biosciences5/12/2026Lower Price Target$4.12$5.50Equal Weight$0.0000.00% ROITXG10x Genomics5/12/2026Boost Price Target$20.86$22.00Equal Weight$0.0000.00% ROIADPTAdaptive Biotechnologies5/12/2026Lower Price Target$13.31$18.00Equal Weight$0.0000.00% ROISTVNStevanato Group3/6/2026Lower Price Target$15.21$19.00Equal Weight$0.0000.00% ROIVCYTVeracyte3/5/2026Lower Price Target$34.68$37.00Underweight$0.0000.00% ROIPSNLPersonalis3/5/2026Lower Price Target$8.65$10.00Equal Weight$0.0000.00% ROINTRANatera3/3/2026Lower Price Target$201.97$250.00Overweight$0.0000.00% ROITEMTempus AI3/3/2026Lower Price Target$50.52$70.00Overweight$0.0000.00% ROIIQVIQVIA2/11/2026Set Price Target$177.89$240.00$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. TMOThermo Fisher Scientific12/2/2025Boost Price Target$581.50$670.00Overweight$0.0000.00% ROIVCYTVeracyte12/1/2025Boost Price Target$46.39$48.00Underweight$0.0000.00% ROITEMTempus AI12/1/2025Boost Price Target$74.07$85.00Overweight$0.0000.00% ROISTVNStevanato Group12/1/2025Initiated Coverage$22.64$24.00Equal Weight$0.0000.00% ROINTRANatera12/1/2025Boost Price Target$234.25$265.00Overweight$0.0000.00% ROIIQVIQVIA12/1/2025Boost Price Target$228.48$265.00Overweight$0.0000.00% ROIGHGuardant Health12/1/2025Boost Price Target$105.22$130.00Overweight$0.0000.00% ROIGRALGRAIL12/1/2025Boost Price Target$98.27$110.00Equal Weight$0.0000.00% ROIADPTAdaptive Biotechnologies11/11/2025Boost Price Target$14.39$16.00Equal Weight$0.0000.00% ROIVCYTVeracyte11/11/2025Boost Price Target$43.08$40.00Underweight$0.0000.00% ROITEMTempus AI11/11/2025Boost Price Target$73.40$80.00Overweight$0.0000.00% ROISTVNStevanato Group11/11/2025Boost Price Target$24.53$26.00Equal Weight$0.0000.00% ROIPSNLPersonalis11/11/2025Boost Price Target$8.41$9.00Equal Weight$0.0000.00% ROINTRANatera11/11/2025Boost Price Target$208.87$220.00Overweight$0.0000.00% ROIHOLXHologic11/11/2025Boost Price Target$74.60$76.00Equal Weight$0.0000.00% ROITMOThermo Fisher Scientific10/28/2025Boost Price Target$563.03$656.00Overweight$0.0000.00% ROITXG10x Genomics8/12/2025Lower Price Target$12.31$17.00Overweight$0.0000.00% ROITEMTempus AI8/12/2025Boost Price Target$60.82$68.00Overweight$0.0000.00% ROIVCYTVeracyte8/8/2025Set Price Target$27.37$28.00Underweight$0.0000.00% ROIILMNIllumina8/4/2025Boost Price Target$96.82$105.00Equal Weight$0.0000.00% ROIAVTRAvantor8/4/2025Lower Price Target$11.40$12.00Equal Weight$0.0000.00% ROIHOLXHologic7/31/2025Boost Price Target$66.85$69.00Equal Weight$0.0000.00% ROINEONeoGenomics7/30/2025Set Price Target$5.22$8.00Equal Weight$0.0000.00% ROICTKBCytek Biosciences5/28/2025Lower Price Target$2.49$7.00Equal Weight$0.0000.00% ROITXG10x Genomics5/19/2025Lower Price Target$9.01$18.00Overweight$00.0000.00% ROIILMNIllumina5/12/2025Lower Price Target$80.00$100.00Equal Weight$000.0000.00% ROITEMTempus AI5/9/2025Boost Price Target$62.51$65.00Overweight$00.0000.00% ROICYRXCryoPort5/5/2025Lower Price Target$5.74$7.00Equal Weight$00.0000.00% ROIADPTAdaptive Biotechnologies5/5/2025Boost Price Target$9.72$9.00Equal Weight$00.0000.00% ROIHOLXHologic5/5/2025Lower Price Target$53.82$65.00Equal Weight$0.0000.00% ROII was right about SpaceX (Ad)Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.See how to claim your stake in SpaceX before the public canNEONeoGenomics5/1/2025Lower Price Target$7.02$10.00Equal Weight$0.0000.00% ROIAVTRAvantor4/28/2025Set Price Target$12.93$15.00Equal Weight$0.0000.00% ROIMRVIMaravai LifeSciences3/25/2025Lower Price Target$2.35$5.00Equal Weight$0.0000.00% ROIGRALGRAIL3/18/2025Boost Price Target$27.06$20.00Equal Weight$00.0000.00% ROITEMTempus AI3/6/2025Boost Price Target$53.06$60.00Overweight$00.0000.00% ROINTRANatera3/5/2025Boost Price Target$142.35$185.00Overweight$000.0000.00% ROITXG10x Genomics2/14/2025Lower Price Target$11.94$26.00Overweight$00.0000.00% ROIIQVIQVIA2/11/2025Boost Price Target$201.54$250.00Overweight$000.0000.00% ROIILMNIllumina2/11/2025Lower Price Target$102.44$136.00Equal Weight$000.0000.00% ROIAVTRAvantor2/10/2025Lower Price Target$18.82$25.00Overweight$00.0000.00% ROITMOThermo Fisher Scientific1/31/2025Boost Price Target$602.56$678.00Overweight$000.0000.00% ROITXG10x Genomics1/13/2025Lower Price Target$16.43$28.00Overweight$00.0000.00% ROIHOLXHologic1/13/2025Lower Price Target$70.44$82.00Equal Weight$00.0000.00% ROIILMNIllumina1/13/2025Lower Price Target$143.81$150.00Equal Weight$000.0000.00% ROITMOThermo Fisher Scientific1/13/2025Lower Price Target$556.53$647.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.